SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine, provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits. SAGA Diagnostics is revolutionizing cancer diagnostics and monitoring, with its ultrasensitive testing services and kits.
Ultrasensitive Liquid Biopsy Testing Services
SAGA Diagnostics is a liquid biopsy testing specialist, providing ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency. The company’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.
SAGA Diagnostics’ liquid biopsy testing services are minimally-invasive, enabling patients to avoid the discomfort and risk associated with invasive tissue biopsies. The company’s tests are based on the detection of ctDNA, which is released into the bloodstream by cancer cells and can be used to monitor disease progression and treatment response. SAGA Diagnostics’ ultrasensitive liquid biopsy testing services provide patients with a more accurate diagnosis and treatment monitoring, improving patient outcomes and survival.
Experienced Management Team and Renowned Scientists
SAGA Diagnostics’ experienced management team and renowned scientists are at the forefront of the ongoing revolution in cancer research, drug development, and clinical diagnostics. The company’s team consists of highly qualified staff who work together to launch SAGA’s ultrasensitive services and products. The company’s management team has extensive experience in the biotechnology industry, and its scientists are recognized leaders in the field of cancer genetics.
SAGA Diagnostics’ team is committed to improving precision cancer medicine and providing patients with the most advanced cancer diagnostics and monitoring available. The company’s team is focused on delivering high-quality liquid biopsy testing services and kits that can improve patient outcomes and survival.
Revolutionizing Cancer Diagnostics and Monitoring
SAGA Diagnostics is revolutionizing cancer diagnostics and monitoring with its ultrasensitive liquid biopsy testing services and kits. The company’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.
SAGA Diagnostics’ liquid biopsy testing services and kits are minimally-invasive, enabling patients to avoid the discomfort and risk associated with invasive tissue biopsies. The company’s tests are based on the detection of ctDNA, which is released into the bloodstream by cancer cells and can be used to monitor disease progression and treatment response. SAGA Diagnostics’ ultrasensitive liquid biopsy testing services and kits provide patients with a more accurate diagnosis and treatment monitoring, improving patient outcomes and survival.
Conclusion
In conclusion, SAGA Diagnostics AB is a startup that is revolutionizing cancer diagnostics and monitoring with its ultrasensitive liquid biopsy testing services and kits. The company’s experienced management team and renowned scientists are committed to improving precision cancer medicine and providing patients with the most advanced cancer diagnostics and monitoring available. With its proprietary tests, SAGA Diagnostics is at the forefront of the ongoing revolution in cancer research, drug development, and clinical diagnostics.
Website: http://sagadiagnostics.com/
Twitter: https://twitter.com/sagadiagnostics
Facebook: https://www.facebook.com/SAGAdiagnostics/
LinkedIn: https://www.linkedin.com/company/saga-diagnostics-ab
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
